Suzanne Oparil Selected Research

BQ 610

5/2012	Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure.
5/2007	Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung.
5/2005	Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.
12/2002	Endothelin-A receptor blockade in porcine pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne Oparil Research Topics

Disease

181	Hypertension (High Blood Pressure) 12/2022 - 01/2002
48	Myocardial Infarction 11/2021 - 03/2002
33	Stroke (Strokes) 12/2021 - 03/2002
32	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 03/2002
26	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 03/2002
19	Heart Failure 01/2022 - 04/2008
17	Hypoxia (Hypoxemia) 05/2012 - 02/2002
16	Inflammation (Inflammations) 01/2019 - 10/2003
14	Vascular Remodeling 07/2014 - 02/2002
13	Chronic Renal Insufficiency 12/2021 - 05/2003
11	Obesity 11/2022 - 01/2010
11	Neointima 01/2017 - 08/2002
9	Hypertrophy 01/2019 - 05/2003
8	Isolated Systolic Hypertension 12/2022 - 09/2002
8	Diabetes Mellitus 01/2018 - 09/2002
8	Obstructive Sleep Apnea 09/2017 - 03/2009
8	Vascular System Injuries 01/2017 - 01/2004
7	Hyperaldosteronism (Conn Syndrome) 01/2022 - 10/2007
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
7	Cardiomegaly (Heart Hypertrophy) 12/2013 - 05/2003
5	Weight Loss (Weight Reduction) 01/2020 - 03/2009
5	Pulmonary Hypertension 12/2011 - 12/2002
4	Neoplasms (Cancer) 08/2022 - 10/2010
4	Hypotension (Low Blood Pressure) 01/2021 - 11/2015
4	Prehypertension 01/2021 - 04/2006
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 11/2015
4	Syncope (Fainting) 01/2021 - 11/2015
4	Albuminuria 01/2019 - 09/2004
4	Chronic Kidney Failure (Chronic Renal Failure) 03/2015 - 05/2009
4	Insulin Resistance 12/2013 - 11/2005
4	Fibrosis (Cirrhosis) 09/2011 - 11/2004
4	Essential Hypertension 01/2008 - 08/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2005
3	Infarction (Infarctions) 01/2018 - 02/2012
3	Vascular Diseases (Vascular Disease) 07/2013 - 08/2003

Drug/Important Bio-Agent (IBA)

110	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 03/2002
32	LipidsIBA 11/2022 - 05/2003
28	DiureticsIBA 01/2022 - 03/2002
27	Amlodipine (Norvasc)FDA LinkGeneric 01/2021 - 09/2006
25	Losartan (Cozaar)FDA LinkGeneric 03/2009 - 03/2002
21	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2021 - 09/2006
21	Atenolol (Tenormin)FDA LinkGeneric 11/2013 - 03/2002
19	AldosteroneIBA 01/2021 - 04/2003
17	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2003
17	Pharmaceutical PreparationsIBA 12/2020 - 01/2002
16	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020 - 01/2005
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 05/2003
15	SodiumIBA 01/2022 - 06/2006
15	Lisinopril (Prinivil)FDA LinkGeneric 01/2021 - 09/2006
14	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 05/2003
13	Olmesartan Medoxomil (Votum)FDA Link 01/2020 - 03/2007
13	Atrial Natriuretic Factor (ANF)IBA 10/2011 - 02/2002
11	ReninIBA 01/2017 - 07/2007
10	ThiazidesIBA 11/2020 - 05/2003
10	SaltsIBA 01/2020 - 02/2002
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2003
10	Estrogens (Estrogen)FDA Link 07/2015 - 10/2003
9	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2009
9	Messenger RNA (mRNA)IBA 07/2011 - 08/2003
8	Dietary SodiumIBA 01/2020 - 06/2006
8	Valsartan (Vals)FDA Link 01/2017 - 01/2005
8	CollagenIBA 08/2013 - 07/2003
8	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2012 - 02/2006
7	aliskiren FDA Link 02/2013 - 07/2007
6	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 12/2003
6	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 03/2008
6	olmesartanIBA 01/2018 - 01/2008
6	Renin InhibitorsIBA 10/2012 - 09/2007
6	Transforming Growth Factor beta (TGF-beta)IBA 02/2010 - 02/2006
5	PotassiumIBA 10/2018 - 03/2008
5	CytokinesIBA 01/2018 - 10/2003
5	Interleukin-8 ReceptorsIBA 01/2017 - 03/2012
5	salicylhydroxamic acid (SHAM)IBA 05/2016 - 09/2006
5	Valsartan Drug Combination Amlodipine FDA Link 01/2014 - 12/2009
5	C-Reactive ProteinIBA 01/2014 - 10/2003
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 07/2003
5	Endothelin A ReceptorIBA 05/2012 - 12/2002
5	Angiotensin IIIBA 01/2009 - 08/2003
5	N-propionylprocainamideIBA 09/2006 - 05/2003
4	ElectrolytesIBA 01/2021 - 11/2015
4	CreatinineIBA 01/2019 - 09/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2009
4	Endothelin-1 (Endothelin 1)IBA 01/2017 - 01/2007
4	BQ 610IBA 05/2012 - 12/2002
4	PeriostinIBA 10/2006 - 07/2003
4	OsteopontinIBA 08/2006 - 08/2002
3	Doxazosin (Cardura)FDA LinkGeneric 01/2021 - 09/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2005
3	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 12/2012
3	Interleukin-8 (Interleukin 8)IBA 07/2014 - 03/2012
3	AlbuminsIBA 09/2013 - 09/2004
3	Hormones (Hormone)IBA 07/2013 - 10/2003
3	Neutralizing AntibodiesIBA 05/2012 - 07/2011

Therapy/Procedure

56	Therapeutics 11/2022 - 08/2002
11	Denervation 12/2017 - 02/2012
6	Bariatric Surgery 01/2020 - 02/2017
6	Drug Therapy (Chemotherapy) 05/2017 - 11/2005
4	Catheters 04/2015 - 02/2012
3	Ambulatory Care (Outpatient Care) 01/2021 - 01/2019
3	Secondary Prevention 10/2016 - 01/2003